(1) "Board of Pharmaceutical Specialties" (BPS) means an independent nongovernmental certification body that provides recognition of persons involved in the advanced practice of pharmacy specialties through development and administration, a certification process that is consistent with public policy regarding the credentialing of healthcare professionals.
(2) "Clinical practice experience" means working in a pharmacy practice setting which includes at least 50 percent of time spent in:
(a) communication with healthcare professionals and patients regarding drug therapy, wellness, and health promotion;
(b) designing, implementing, monitoring, evaluating, and modifying or recommending modifications in drug therapy to optimize patient care;
(c) identifying, assessing, and solving medication-related problems and providing a clinical judgment as to the continuing effectiveness of the therapeutic plan;
(d) conducting physical assessment applicable to the area of practice, evaluating patient problems, ordering and monitoring medications, and/or laboratory tests in accordance with established standards of practice;
(e) referring patients to other healthcare professionals as appropriate;
(f) integrating relevant diet, exercise, and other non-drug therapy with pharmaceutical care;
(g) retrieving, evaluating, utilizing, and managing data and professional resources;
(h) documenting interventions and evaluating outcomes; and
(i) integrating national standards for the quality of healthcare.
(3) "Collaborative practice agreement" is defined as set forth in ARM 24.174.524.
History: 37-7-201, MCA; IMP, 37-7-201, 37-7-306, MCA; NEW, 2010 MAR p. 2968, Eff. 12/24/10.